NasdaqCM:LLIT

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. More Details


Snowflake Analysis

Adequate balance sheet and overvalued.


Similar Companies

Share Price & News

How has Lianluo Smart's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: LLIT is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 17% a week.

Volatility Over Time: LLIT's weekly volatility has decreased from 33% to 17% over the past year, but is still higher than 75% of US stocks.


Market Performance


7 Day Return

34.0%

LLIT

-1.5%

US Medical Equipment

2.1%

US Market


1 Year Return

22.3%

LLIT

16.3%

US Medical Equipment

19.8%

US Market

Return vs Industry: LLIT exceeded the US Medical Equipment industry which returned 16.3% over the past year.

Return vs Market: LLIT exceeded the US Market which returned 19.7% over the past year.


Shareholder returns

LLITIndustryMarket
7 Day34.0%-1.5%2.1%
30 Day5.8%-0.3%8.1%
90 Day46.5%2.7%6.0%
1 Year22.3%22.3%17.2%16.3%22.5%19.8%
3 Year-65.8%-65.8%67.0%62.7%46.5%36.8%
5 Year-73.0%-73.0%139.1%120.8%96.9%75.3%

Long-Term Price Volatility Vs. Market

How volatile is Lianluo Smart's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Lianluo Smart undervalued compared to its fair value and its price relative to the market?

4.2x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate LLIT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate LLIT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: LLIT is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: LLIT is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate LLIT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LLIT is good value based on its PB Ratio (4.2x) compared to the US Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is Lianluo Smart forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

25.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lianluo Smart has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Lianluo Smart performed over the past 5 years?

9.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: LLIT is currently unprofitable.

Growing Profit Margin: LLIT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: LLIT is unprofitable, but has reduced losses over the past 5 years at a rate of 9.3% per year.

Accelerating Growth: Unable to compare LLIT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LLIT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.2%).


Return on Equity

High ROE: LLIT has a negative Return on Equity (-67.11%), as it is currently unprofitable.


Next Steps

Financial Health

How is Lianluo Smart's financial position?


Financial Position Analysis

Short Term Liabilities: LLIT's short term assets ($7.9M) exceed its short term liabilities ($3.3M).

Long Term Liabilities: LLIT's short term assets ($7.9M) exceed its long term liabilities ($689.9K).


Debt to Equity History and Analysis

Debt Level: LLIT's debt to equity ratio (47%) is considered high.

Reducing Debt: LLIT's debt to equity ratio has increased from 6.7% to 47% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LLIT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: LLIT has sufficient cash runway for 2.5 years if free cash flow continues to grow at historical rates of 2% each year.


Next Steps

Dividend

What is Lianluo Smart current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate LLIT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate LLIT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if LLIT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LLIT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LLIT's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Bin Lin (55 yo)

0.25

Tenure

Mr. Bin Lin serves as the Chairman of Beijing Huitu Information Technology Co., Ltd. since December 2013. Mr. Lin served as a Director of Hangzhou Liaison Interactive Information Technology Co., Ltd. Mr. L...


Leadership Team

NamePositionTenureCompensationOwnership
Ping Chen
no dataUS$27.77k5.6%
$ 994.3k
Yingmei Yang
Interim CFO & Director0.58yrno datano data
Bin Lin
CEO & Chairman0.25yrno datano data
Fei Dong
Director of Operationsno datano datano data
Xiaoqing Wang
Chief Technology Officer9.33yrsno datano data
Lisa Zhou
Investor Relations Managerno datano datano data
Li Sun
Vice President and Director of Salesno datano datano data

2.7yrs

Average Tenure

55yo

Average Age

Experienced Management: LLIT's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yingmei Yang
Interim CFO & Director0.58yrno datano data
Bin Lin
CEO & Chairman0.25yrno datano data
Fuya Zheng
Independent Director0.58yrno datano data
Bin Pan
Independent Director4.08yrsUS$8.00kno data
Zhiqiang Chang
Independent Director4.08yrsUS$8.00kno data

0.6yrs

Average Tenure

53yo

Average Age

Experienced Board: LLIT's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 61.7%.


Top Shareholders

Company Information

Lianluo Smart Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Lianluo Smart Limited
  • Ticker: LLIT
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$17.746m
  • Shares outstanding: 3.60m
  • Website: https://www.lianluosmart.com

Number of Employees


Location

  • Lianluo Smart Limited
  • BeiKong Technology Building
  • 6th Floor
  • Beijing
  • 102200
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LLITNasdaqCM (Nasdaq Capital Market)YesClass A Common SharesUSUSDApr 2010
J8D1DB (Deutsche Boerse AG)YesClass A Common SharesDEEURApr 2010

Biography

Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. The company offers medical...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/26 23:35
End of Day Share Price2020/11/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.